Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?

about

Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?

Item

http://www.wikidata.org/entity/Q50540275

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@en

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@nl

type

Item

label

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@en

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@nl

prefLabel

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@en

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@nl

P1476

Does having a gastrectomy dela ...... intraperitoneal chemotherapy?

@en

P2093

Claramae Shulyn Chia

http://www.w3.org/2001/XMLSchema#string

Grace Hwei Ching Tan

http://www.w3.org/2001/XMLSchema#string

Khee Chee Soo

http://www.w3.org/2001/XMLSchema#string

Melissa Ching Teo

http://www.w3.org/2001/XMLSchema#string

Nicholas Brian Shannon

http://www.w3.org/2001/XMLSchema#string

P2860

Is early oral feeding after gastric cancer surgery feasible? A systematic review and meta-analysis of randomized controlled trials

Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Feasibility and outcomes of early oral feeding after total gastrectomy for cancer.

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.

Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02656736.2017.1354133

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28689443

http://www.w3.org/2001/XMLSchema#string

P921

gastrectomy